Geoffrey Parker Joins Sunesis' Board
This article was originally published in Scrip
Sunesis Pharmaceuticals Inc., a company focused on oncology therapeutics, has appointed Geoffrey Parker to its board of directors. Parker brings more than 30 years' of finance and leadership experience to the board and most recently was executive vice president and chief financial officer of Anacor Pharmaceuticals Inc. Parker also has experience working with life sciences companies in various capacities at Goldman Sachs, leading the firm's West Coast healthcare investment banking practice for 12 years. Furthermore, Helen Kim has stepped down from her position as a director.